2024

1. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

   JHEP Reports, Vol. 6, Núm. 1

2. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)

   Gut Microbes, Vol. 16, Núm. 1

3. Cirrhosis-downregulated LSECtin can be retrieved by cytokines, shifts the TLR-induced LSECs secretome and correlates with the hepatic Th response

   Liver International, Vol. 44, Núm. 4, pp. 996-1010

4. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

   Therapeutic Advances in Gastroenterology, Vol. 17

5. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry

   Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74

6. Controversies in the management of anti-TNF therapy in patients with Crohn's disease: a Delphi consensus

   BMJ Open Gastroenterology, Vol. 11, Núm. 1

7. Curcumin encapsulated in milk small extracellular vesicles as a nanotherapeutic alternative in experimental chronic liver disease

   Biomedicine and Pharmacotherapy, Vol. 173

8. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

   Frontiers in Endocrinology, Vol. 15

9. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis

   JHEP Reports, Vol. 6, Núm. 2

10. Hepatic hemodynamic study: More than just HVPG measurement

    Gastroenterologia y Hepatologia

11. Improving the Diagnosis of Dermatitis Herpetiformis Using the Intraepithelial Lymphogram

    Nutrients, Vol. 16, Núm. 2

12. Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury

    Redox Biology, Vol. 71

13. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 401-432

14. Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study

    Annals of Hepatology, Vol. 29, Núm. 3

15. Recommendations on the management of severe obesity in patients with inflammatory bowel disease of the Spanish Group on Crohn's Disease and Ulcerative Colitis (GETECCU), Spanish Society of Obesity (SEEDO), Spanish Association of Surgery (AEC) and Spanish Society of Digestive Endoscopy (SEED)

    Gastroenterologia y Hepatologia

16. Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID)

    Surgical Oncology, Vol. 52

17. Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet

    Pharmacological Research, Vol. 200

18. The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis

    Liver International, Vol. 44, Núm. 2, pp. 279-285

19. Unusual early post-transplant hepatic dysfunction

    Journal of Hepatology, Vol. 80, Núm. 1, pp. e11-e13

20. p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway

    Cell Reports Medicine, Vol. 5, Núm. 2